Stockreport

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Geneva, Switzerland, May 31, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel smal [Read more]